Discover the Future of Synthetic Biology

Date: 31 May 2022 , Tuesday

Time: 09:30 - 14:00 (Singapore Time)

Venue: CELS Auditorium, Centre of Life Science, National University of Singapore, 28 Medical Drive, Singapore 117456

Discover The Future of Synthetic Biology

Please note that lunch will be served after the seminar.

Synthetic Biology is a disruptive approach to bioengineering with the promise of revolutionizing many industries across many sectors of the economy. The breakthroughs in DNA synthesis allow scientists to engineer living organisms in novel ways, and high throughput engineering makes biotech applications in fields such as medicine, sustainable development, agritech, and many more!

In this symposium, SINERGY and Twist Bioscience welcome Emily Leproust, CEO of Twist Bioscience, and a stellar panel of synthetic biology experts from Singapore’s leading institutes to discuss what we can do using synthetic biology, and what the future holds.

Tentative Schedule:

09:30 - 09:45 Registration

09:45 - 09:50 Opening Remarks by Matthew Chang, Director, SINERGY

09:50 - 09:55 Introduction by Jeremy Dumsday, KOSEA Commercial Director, Twist Bioscience

09:55 - 10:30 Writing The Future of Synthetic Biology by Emily Leproust, CEO and Co-Founder, Twist Bioscience

10:30 - 10:55 Chueh Loo Poh, Director of Biofoundry and DNA Data Storage, NUS

10:55 - 11:05 Break

11:05 - 11:30 Yee Hwee Lim, A*STAR

11:30 - 11:55 Sierin Lim, NTU

11:55 - 12:25 Panel Discussion: "Discover the Future of Synthetic Biology'

• Emily Leproust, Twist Bioscience
• Sierin Lim, NTU
• Chueh Loo Poh, NUS
• Yee Hwee Lim, A*STAR
• Kostas Vavitsas (Moderator), SINERGY

12:25 - 12:30 Closing Remarks

12:30 - 14:00 Lunch

Company Description

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.